Clinical Trials List
2025-11-01 - 2027-08-22
Phase II
Recruiting5
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- 黃怡菁 Division of Hematology & Oncology
- 楊舜如 Division of Hematology & Oncology
- Kuo-Ting Lee Division of General Surgery
- 黃怡璇 Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Zhu-Jun Loh Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 高婉真 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Chi Chou Division of Hematology & Oncology
- Ming-Mo Hou Division of Hematology & Oncology
- Chan-Keng Yang Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 柯建佑 Division of Hematology & Oncology
- 蔡郁棻 Division of Hematology & Oncology
- Meng-Jer Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Mu-Hsin Chang Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20-42 participants
-
Global
204 participants